Olivier Pomel - Datadog CEO CoFounder
| 3QD Stock | EUR 147.28 10.34 7.55% |
Insider
Olivier Pomel is CEO CoFounder of Datadog
| Age | 45 |
| Phone | 866 329 4466 |
| Web | https://www.datadoghq.com |
Olivier Pomel Latest Insider Activity
Tracking and analyzing the buying and selling activities of Olivier Pomel against Datadog stock is an integral part of due diligence when investing in Datadog. Olivier Pomel insider activity provides valuable insight into whether Datadog is net buyers or sellers over its current business cycle. Note, Datadog insiders must abide by specific rules, including filing SEC forms every time they buy or sell Datadog'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Olivier Pomel over two months ago Disposition of 9 shares by Olivier Pomel of Datadog at 108.8841 subject to Rule 16b-3 | ||
Olivier Pomel over three months ago Disposition of 35123 shares by Olivier Pomel of Datadog at 131.73 subject to Rule 16b-3 |
Datadog Management Efficiency
The company has return on total asset (ROA) of (0.0136) % which means that it has lost $0.0136 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0409) %, meaning that it generated substantial loss on money invested by shareholders. Datadog's management efficiency ratios could be used to measure how well Datadog manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Funk | United Natural Foods | 69 | |
| Mahrukh Hussain | United Natural Foods | 51 | |
| Curt Craig | TreeHouse Foods | 51 | |
| MBA LLM | Compugroup Medical SE | 51 | |
| Anton Lindqvist | Diamyd Medical AB | 43 | |
| Claudia Thom | Compugroup Medical SE | 52 | |
| Anna BSc | Diamyd Medical AB | 62 | |
| Ulf MBA | Diamyd Medical AB | 48 | |
| Sean Lewis | TreeHouse Foods | 48 | |
| Oliver Bruzek | Compugroup Medical SE | N/A | |
| Steven Bloomquist | United Natural Foods | N/A | |
| Eckart Pech | Compugroup Medical SE | 54 | |
| Alexander Weimer | Compugroup Medical SE | N/A | |
| Patrick ODonnell | TreeHouse Foods | 44 | |
| John Clare | United Natural Foods | 52 | |
| Christopher Testa | United Natural Foods | 53 | |
| Thomas ONeill | TreeHouse Foods | 67 | |
| Philippe Houssiau | SAFETY MEDICAL PROD | 57 | |
| Jeffrey Swanson | United Natural Foods | N/A | |
| Michael Franz | Compugroup Medical SE | N/A | |
| Kristy Waterman | TreeHouse Foods | 42 | |
Management Performance
| Return On Equity | -0.0409 | |||
| Return On Asset | -0.0136 |
Datadog Leadership Team
Elected by the shareholders, the Datadog's board of directors comprises two types of representatives: Datadog inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Datadog. The board's role is to monitor Datadog's management team and ensure that shareholders' interests are well served. Datadog's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Datadog's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Obstler, Chief Officer | ||
| Adam Blitzer, Chief Officer | ||
| Amit Agarwal, President | ||
| Emilio Escobar, Chief Officer | ||
| Kerry JD, G Sec | ||
| Alex Rosemblat, Chief Officer | ||
| Olivier Pomel, CEO CoFounder | ||
| Alexis LeQuoc, CTO CoFounder | ||
| Armelle Madre, Chief Officer | ||
| Alexander CFA, Director FPA |
Datadog Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Datadog a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0409 | |||
| Return On Asset | -0.0136 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 23.37 B | |||
| Shares Outstanding | 294.06 M | |||
| Shares Owned By Insiders | 7.92 % | |||
| Shares Owned By Institutions | 80.97 % | |||
| Price To Book | 19.52 X | |||
| Price To Sales | 14.74 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Datadog Stock
When determining whether Datadog is a strong investment it is important to analyze Datadog's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Datadog's future performance. For an informed investment choice regarding Datadog Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Datadog. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Datadog Stock please use our How to Invest in Datadog guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.